Celator Pharmaceuticals (CPXX) Tops Q3 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. CMG
7. TENB
8. BIIB
9. KLAC
10. ETSY

Go back to Celator Pharmaceuticals (CPXX) Tops Q3 EPS by 1c

Celator® Pharmaceuticals Announces Third Quarter 2015 Financial Results and Business Update

November 12, 2015 4:05 PM EST

EWING, N.J., Nov. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) today reported business highlights and financial results for the third quarter ended September 30, 2015.

"The momentum builds as we continue to deliver on our milestones, from the induction response rate improvement observed in our Phase 3 study with VYXEOS (formerly CPX-351) and announced last quarter, to impressive results from data packages on novel combination programs," said Scott Jackson, Chief Executive Officer of the Company.  "The external validation of our proprietary technologies, as evidenced with VYXEOS being selected as the... More